SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Amendment No. 1)*

Under the Securities Exchange Act of 1934

Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

* See Item 4 for additional information.

* See Item 4 for additional information.

Item 1(a). Name Of Issuer:

Safeguard Scientifics, Inc. (the “Company”).

Item 1(b). Address of Issuer’s Principal Executive Offices:

150 N. Radnor Chester Road Suite F-200 Radnor, PA 19087.

Item 2(a). Name of Person Filing:

This report on Schedule 13G (this “Schedule 13G”) is being filed by the Halis Family Foundation (“HFF”) and Jeffrey Halis.

Item 2(b). Address of Principal Business Office or, if None, Residence:

The address for HFF and Mr. Halis is 150 East 58^th Street, 14^th Floor, NY, NY 10155.

Item 2(c). Citizenship:

HFF is a New York Trust. Mr. Halis is a citizen of the United States of America.

Item 2(d). Title of Class of Securities:

Common Stock, par value $0.10 per share.

Item 2(e). CUSIP No.

786449306.

Item 3. If This Statement Is Filed Pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

Not Applicable.

Item 4. Ownership.

As reported in the cover pages to this report, the ownership information with respect to Halis is as follows:

* Based on 16,575,618 shares of common stock, par value $0.10 (the “Shares”), of the Company, outstanding as of October 30, 2023, as disclosed in the Company’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2023. As of December 31, 2023, 843,311 Shares are owned by HFF. Jeffrey Halis is the trustee of HFF, and possesses the sole power to vote and the sole power to direct the disposition of all Shares held by HFF. As a result of the foregoing, for purposes of Reg. Section 240.13d-3, Mr. Halis may be deemed to beneficially own the 843,311 Shares of the Company held by HFF, or 5.1% of the Shares of the Company deemed to be issued and outstanding as of December 31, 2023.

Item 5. Ownership of Five Percent or Less of a Class.

Not Applicable.

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

Not Applicable.

Item 9. Notice of Dissolution of Group.

Not Applicable.

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Attention: Intentional misstatements or omissions of fact constitute

Federal criminal violations (See 18 U.S.C. 1001)

Exhibit Index